anidulafungin has been researched along with Kidney Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azanza, JR; Montejo, M | 1 |
| Böhmdorfer, M; Fuhrmann, V; Jäger, W; Leitner, JM; Meyer, B; Saria, K; Thalhammer, F; Zuba, C | 1 |
| Damle, B; Dowell, JA; Krause, D; Stogniew, M | 1 |
1 review(s) available for anidulafungin and Kidney Failure
| Article | Year |
|---|---|
[Pharmacokinetics and pharmacodynamics: interactions and adverse effects. Comparison with other echinocandins].
Topics: Aged; Anidulafungin; Antifungal Agents; Caspofungin; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Monitoring; Echinocandins; Gastrointestinal Diseases; Half-Life; Humans; Immunosuppressive Agents; Lipopeptides; Liver; Liver Failure; Mycoses; Obesity; Renal Insufficiency; Tissue Distribution | 2008 |
1 trial(s) available for anidulafungin and Kidney Failure
| Article | Year |
|---|---|
Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment.
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Area Under Curve; Echinocandins; Female; Half-Life; Hepatic Insufficiency; Humans; Male; Metabolic Clearance Rate; Middle Aged; Peptides, Cyclic; Renal Insufficiency | 2007 |
1 other study(ies) available for anidulafungin and Kidney Failure
| Article | Year |
|---|---|
Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.
Topics: Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Chemoprevention; Echinocandins; Female; Hemofiltration; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Renal Insufficiency | 2011 |